Celcuity Inc (CELC)
14.13
-0.50
(-3.42%)
USD |
NASDAQ |
Nov 14, 16:00
14.13
0.00 (0.00%)
After-Hours: 20:00
Celcuity Total Assets (Quarterly): 292.54M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 292.54M |
March 31, 2024 | 188.18M |
December 31, 2023 | 191.22M |
September 30, 2023 | 142.38M |
June 30, 2023 | 153.52M |
March 31, 2023 | 164.88M |
December 31, 2022 | 175.70M |
September 30, 2022 | 65.29M |
June 30, 2022 | 72.35M |
March 31, 2022 | 79.93M |
December 31, 2021 | 85.91M |
September 30, 2021 | 91.84M |
June 30, 2021 | 42.81M |
March 31, 2021 | 36.37M |
December 31, 2020 | 12.96M |
Date | Value |
---|---|
September 30, 2020 | 14.91M |
June 30, 2020 | 16.70M |
March 31, 2020 | 18.39M |
December 31, 2019 | 20.28M |
September 30, 2019 | 21.74M |
June 30, 2019 | 23.44M |
March 31, 2019 | 24.94M |
December 31, 2018 | 26.03M |
September 30, 2018 | 27.89M |
June 30, 2018 | 29.47M |
March 31, 2018 | 30.73M |
December 31, 2017 | 31.97M |
September 30, 2017 | 33.15M |
June 30, 2017 | 11.69M |
December 31, 2016 | 6.057M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.96M
Minimum
Dec 2020
292.54M
Maximum
Jun 2024
98.22M
Average
79.93M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
CEL-SCI Corp | 24.07M |
AIM ImmunoTech Inc | 15.72M |
IGC Pharma Inc | 10.59M |
NovaBay Pharmaceuticals Inc | 3.925M |
Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 115.86M |
Shareholders Equity (Quarterly) | 176.68M |